EZH2 and neoplasm: Translated to the clinic this would imply that before targeting EZH2 in the context of MPNST it is imperative to verify whether the PRC2 complex is in fact inactivated e.g. by determining the absence of H3K27 trimethylation (H3K27me3) in the tumor tissue.